Last year the company had pretty good sales before the voluntary market withdraw. Today we have sales ramping back up, a clear marketing strategy, and 2 potential marketing partners in the DES arena. So I would say that for NSPR not to be trading back up around $1 a share within a year would not be unreasonable. At $1 dollar a share that would bring the market cap back to where it was. So I think entering with a new position here or doubling up if you are underwater the Risk / Reward Ratio is favorable. JMHO
Blue Balls Mike = Liar
Mr. Alan W. Milinazzo joined NSPR in Jan. 2013 when stock was at $3.5 and share not $11.
Alan was being about $500k a year
Now he and the BOD are not taking any compensation because of some misteps by past management direction withpursuing Bare Mr=etal Stents instead of DES here in the US.
Alan is married and has been for a long time he is not out chasing women around nor does he have drug problem.
You have completely misrepresented your statements as they are out right lies ===You go in the idiot book with Ice -Ice baby
More like a PE of 19......instItutions are buying CELG on future earrings not past earnings.
However, that said you will not see these stocks prices this low forever either. To get rich or make serious money it takes time.
1) Sales Ramping in Europe these guys can break even at $1 million a month in sales and that is nothing with the size of the market place they are going after and penetrating .
2) DES stent partner in US by 3 quarter.
3) Work on FDA protocol for clinical trial 2016 with Partner 2017. Hopefully upfront money and mile stones will provide cash they need to which will eliminate any further dilution.
4) Potential DES mesh covered stent into market by 2018 is US.
5) Potential sales easily $500 million.
6) NPSR will either sell company or be making great margins.
7) By 2018 to 2020 NSPR can be easily be a $20 to $30 dollar a share stock with $500 million in sales.
8) Soild Managament team that is important.
8) Management has skin in the game with many shares bought in open market and remember they want to get rich to.
No it it won't go to .20 cents I will make a bet with you ! Selling was exhausted at about .28 ...Market cap here should be about $100 million when sales return in the EU and NSPR re enters the DES market in the US with a strategic partner ... Lots of money to be made here. Risk is not to the down side ...
Yoko Ono was here long before you were ice ice baby he was I posting comentary that was irrelvent to NSPR ..both postive and negative,,, he is not a paid pumper that is a joke what is a joke is whatever you post here which is pure nonsense and the real joke. You are mindless worm with nothing better to do in your poor sad little patethic life where you probably live in a one bedroom apartment or at home with yoir mommy...lol
There is nothing you can do at this pont you would think these guys would have some sort of announcement that is postive going forward now that this is out of the way. After hours is after hours nonsense with people dumping at any cost.
Please short this .35 stock camsham..lol
No hedge fund in their right mind would be shorting a stock this low ! The risk reward is not worth it
We will be looking for some positive news in the days, weeks and months ahead. Stock should move higher from here. We see no reason why NSPR can not be a $1 stock this year, $2 dollar stock 2016 and a $3 and higher stock in 2017. Good Luck.
hey ding #$%$ that .23 cents print was just panick selling and you would have been to be Houdini himself get any stock there... ice ice baby...But nice try as you are wrong with everything you say... It is entertaining however..lol
Phew this is a roller coaster here I am hanging tough Yoko ...Damn !
Not a paid pumper at all I am a retired money manager .... I have taken a position in this stock to the long side and will wait it out 3 years or more as will Sol Barer who has a very big investment here. Good Luck, nit wit
That is exactly what I am and I have a made a small fortune in the Biotech area over a 15 year period .... This position here is one of over 40 positions I own. I have spoken and met with Alan ... Expressed my concerns on several topics and feel comfortable that he and his management team can and will execute their plan of action. I think getting a partner in the DES market for the U.S. will be key to their success. If they are unable to get that accomplishedI I will sell my stock. However, I think they can get it done ....Good luck iced numb nuts
Ok now let's look at the potential numbers at 130,000 cases a year and at 10% market penetration that would be 13,000 procedures per year at $9,000 a stent apprx that is $117 million dollars a year just for that procedure alone....Do you see how quickly the numbers add up ? This company with a little help from let's say a partner like SPNC this stock in 2 to 3 years can be a easily a $10 a share stock and or even $20 dollar a share stock.